P42167 (LAP2B_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 138.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Lamina-associated polypeptide 2, isoforms beta/gamma Alternative name(s): Thymopoietin, isoforms beta/gamma Short name=TP beta/gamma Thymopoietin-related peptide isoforms beta/gamma Short name=TPRP isoforms beta/gamma Cleaved into the following 2 chains:
| ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 454 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May help direct the assembly of the nuclear lamina and thereby help maintain the structural organization of the nuclear envelope. Possible receptor for attachment of lamin filaments to the inner nuclear membrane. May be involved in the control of initiation of DNA replication through its interaction with NAKAP95. TP and TP5 may play a role in T-cell development and function. TP5 is an immunomodulating pentapeptide. |
| Subunit structure | Interacts with LMNB1, LMNB2, BANF1, AKAP8L, GMCL and chromosomes By similarity. Ref.5 Ref.6 |
| Subcellular location | Nucleus inner membrane; Single-pass type II membrane protein. Note: Tightly associated with the nuclear lamina. |
| Tissue specificity | Expressed in many tissues. Most abundant in adult thymus and fetal liver. |
| Domain | Has two structurally independent, non-interacting domains: LEM-like (also called LAP2-N or LEM-D) and LEM (also called LAP2-C or LEM-B). LEM-like binds DNA while LEM interacts with BANF1. |
| Post-translational modification | Mitosis-specific phosphorylation specifically abolishes its binding to lamin B and chromosomes By similarity. |
| Pharmaceutical use | TP5 is available under the names Timunox (Cilag), Sintomodulina (Italofarmaco) and Mepentil (Recordati). Used in primary and secondary immune deficiencies, autoimmunity, infections and cancer. |
| Sequence similarities | Belongs to the LEM family. Contains 1 LEM domain. Contains 1 LEM-like domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Membrane Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Signal-anchor Transmembrane Transmembrane helix |
| Ligand | DNA-binding |
| PTM | Phosphoprotein |
| Technical term | Complete proteome Pharmaceutical Reference proteome |
| Gene Ontology (GO) | |
| Cellular_component | integral to membrane Inferred from electronic annotation. Source: UniProtKB-KW nuclear envelopeTraceable author statement Ref.4. Source: ProtInc nuclear inner membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular_function | DNA binding Inferred from electronic annotation. Source: UniProtKB-KW lamin bindingTraceable author statement Ref.4. Source: ProtInc |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| NCK1 | P16333 | 2 | EBI-455283,EBI-389883 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] Note: Additional isoforms seem to exist. | ||||||
| Isoform Beta (identifier: P42167-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Alpha (identifier: P42166-1) The sequence of this isoform can be found in the external entry P42166. Isoforms of the same protein are often annotated in two different entries if their sequences differ significantly. | ||||||
| Isoform Gamma (identifier: P42167-2) The sequence of this isoform differs from the canonical sequence as follows: 222-330: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 454 | 454 | Lamina-associated polypeptide 2, isoforms beta/gamma | PRO_0000045841 | |||||
| Peptide | 1 – 50 | 50 | Thymopoietin | PRO_0000017677 | |||||
| Peptide | 33 – 37 | 5 | Thymopentin | PRO_0000017678 | |||||
Regions | |||||||||
| Transmembrane | 411 – 434 | 24 | Helical; Signal-anchor for type II membrane protein; Potential | ||||||
| Topological domain | 435 – 454 | 20 | Lumenal Potential | ||||||
| Domain | 5 – 48 | 44 | LEM-like | ||||||
| Domain | 109 – 153 | 45 | LEM | ||||||
| Region | 1 – 410 | 410 | Nucleoplasmic Potential | ||||||
| Region | 49 – 108 | 60 | Linker | ||||||
| Region | 138 – 243 | 106 | NAKAP95-binding N | ||||||
| Region | 299 – 371 | 73 | Binds lamins B | ||||||
| Region | 300 – 374 | 75 | NAKAP95-binding C | ||||||
Amino acid modifications | |||||||||
| Modified residue | 66 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 67 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 74 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 156 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 160 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 177 | 1 | Phosphoserine Ref.13 | ||||||
| Modified residue | 180 | 1 | Phosphoserine Ref.13 | ||||||
| Modified residue | 184 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 208 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 211 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 265 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 292 | 1 | Phosphoserine Ref.14 | ||||||
| Modified residue | 306 | 1 | Phosphoserine Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 | ||||||
| Modified residue | 312 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 315 | 1 | Phosphoserine Ref.11 Ref.13 Ref.15 | ||||||
| Modified residue | 362 | 1 | Phosphoserine Ref.13 | ||||||
| Modified residue | 385 | 1 | Phosphoserine Ref.13 | ||||||
Natural variations | |||||||||
| Alternative sequence | 222 – 330 | 109 | Missing in isoform Gamma. | VSP_004456 | |||||
| Natural variant | 287 | 1 | A → P. Corresponds to variant rs7133258 [ dbSNP | Ensembl ]. | VAR_049779 | |||||
| Natural variant | 427 | 1 | L → F. Corresponds to variant rs1058288 [ dbSNP | Ensembl ]. | VAR_014786 | |||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Three distinct human thymopoietins are derived from alternatively spliced mRNAs." Harris C.A., Andryuk P.J., Cline S.W., Chan H.K., Natarajan A., Siekierka J.J., Goldstein G. Proc. Natl. Acad. Sci. U.S.A. 91:6283-6287(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA; BETA AND GAMMA). Tissue: Thymus. |
| [2] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA). Tissue: Eye. |
| [3] | Yu W., Gibbs R.A. Submitted (JUN-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GAMMA). Tissue: Brain. |
| [4] | "Structure and mapping of the human thymopoietin (TMPO) gene and relationship of human TMPO beta to rat lamin-associated polypeptide 2." Harris C.A., Andryuk P.J., Cline S.W., Siekierka J.J., Goldstein G. Genomics 28:198-205(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-237 AND 313-454 (ISOFORMS BETA AND GAMMA). |
| [5] | "Identification of the lamina-associated-polypeptide-2-binding domain of B-type lamin." Furukawa K., Kondo T. Eur. J. Biochem. 251:729-733(1998) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH LMNB1. |
| [6] | "HA95 and LAP2 beta mediate a novel chromatin-nuclear envelope interaction implicated in initiation of DNA replication." Martins S., Eikvar S., Furukawa K., Collas P. J. Cell Biol. 160:177-188(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH AKAP8L. |
| [7] | "Review: lamina-associated polypeptide 2 isoforms and related proteins in cell cycle-dependent nuclear structure dynamics." Dechat T., Vlcek S., Foisner R. J. Struct. Biol. 129:335-345(2000) [PubMed] [Europe PMC] [Abstract] Cited for: TOPOLOGY. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network: indicating the involvement of ribonucleoside-diphosphate reductase M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal transduction." Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S., Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R. Mol. Cell. Proteomics 6:1952-1967(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [11] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306 AND SER-315, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-177; SER-180; SER-306; SER-315; SER-362 AND SER-385, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292 AND SER-306, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [15] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-208; THR-211; SER-265; SER-306; THR-312 AND SER-315, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [17] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184, MASS SPECTROMETRY. |
| [18] | "Solution structure of the constant region of nuclear envelope protein LAP2 reveals two LEM-domain structures: one binds BAF and the other binds DNA." Cai M., Huang Y., Ghirlando R., Wilson K.L., Craigie R., Clore G.M. EMBO J. 20:4399-4407(2001) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 1-169. |
| [19] | "Structural characterization of the LEM motif common to three human inner nuclear membrane proteins." Laguri C., Gilquin B., Wolff N., Romi-Lebrun R., Courchay K., Callebaut I., Worman H.J., Zinn-Justin S. Structure 9:503-511(2001) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 1-57 AND 103-159. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U09087 mRNA. Translation: AAB60330.1. U09088 mRNA. Translation: AAB60331.1. BC053675 mRNA. Translation: AAH53675.1. AF070631 mRNA. Translation: AAC25390.1. U18269 U18270 Genomic DNA. Translation: AAB60434.1.U18271 Genomic DNA. Translation: AAB60435.1. |
| IPI | IPI00030131. IPI00181409. |
| PIR | B55741. C55741. |
| RefSeq | NP_001027454.1. NM_001032283.2. NP_001027455.1. NM_001032284.2. |
| UniGene | Hs.11355. |
3D structure databases | |
| ProteinModelPortal | P42167. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P42167. 7 interactions. |
| MINT | MINT-2839042. |
PTM databases | |
| PhosphoSite | P42167. |
Polymorphism databases | |
| DMDM | 1174690. |
Proteomic databases | |
| PeptideAtlas | P42167. |
| PRIDE | P42167. |
Protocols and materials databases | |
| DNASU | 7112. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000393053; ENSP00000376773; ENSG00000120802. ENST00000556029; ENSP00000450627; ENSG00000120802. |
| GeneID | 7112. |
| KEGG | hsa:7112. |
| UCSC | uc001tfj.3. human. uc001tfk.3. human. |
Organism-specific databases | |
| CTD | 7112. |
| GeneCards | GC12P098909. |
| HGNC | HGNC:11875. TMPO. |
| HPA | CAB009847. HPA008150. |
| MIM | 188380. gene. |
| neXtProt | NX_P42167. |
| PharmGKB | PA36576. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOGENOM | HOG000113280. |
| HOVERGEN | HBG000166. |
| OMA | TGNFKHA. |
Gene expression databases | |
| ArrayExpress | P42167. |
| Bgee | P42167. |
| CleanEx | HS_TMPO. |
| Genevestigator | P42167. |
| GermOnline | ENSG00000120802. Homo sapiens. |
Family and domain databases | |
| Gene3D | 1.10.720.40. 2 hits. |
| InterPro | IPR013146. LEM-like_dom. IPR011015. LEM/LEM-like_dom. IPR003887. LEM_dom. [Graphical view] |
| Pfam | PF03020. LEM. 1 hit. PF08198. Thymopoietin. 1 hit. [Graphical view] |
| SMART | SM00540. LEM. 1 hit. [Graphical view] |
| SUPFAM | SSF63451. LEM_like. 2 hits. |
| PROSITE | PS50954. LEM. 1 hit. PS50955. LEM_LIKE. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | TMPO. human. |
| GenomeRNAi | 7112. |
| NextBio | 27839. |
| PMAP-CutDB | P42167. |
| SOURCE | Search... |
Entry information
| Entry name | LAP2B_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P42167 Secondary accession number(s): Q14861 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
